Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
M
Middle East Pharmaceutical Industries Company SJSC
SAU:4016
Middle East Pharmaceutical Industries Company SJSC
SAU:4016
Price:
121.2
SAR
1.68%
Market Closed
Market Cap:
﷼2.4B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
M
|
Middle East Pharmaceutical Industries Company SJSC
SAU:4016
|
SA |
|
F
|
Freeport-McMoRan Inc
SWB:FPMB
|
US |
|
D
|
DJ Mediaprint & Logistics Ltd
NSE:DJML
|
IN |
|
T
|
TRX Gold Corp
AMEX:TRX
|
CA |
|
W
|
Wereldhave Belgium NV
SWB:WPU
|
BE |
|
Berkeley Group Holdings PLC
F:42B0
|
UK |
|
Almirall SA
MAD:ALM
|
ES |
|
N
|
NTT Inc
F:NTT
|
JP |
|
U
|
UniFirst Corp
F:U1N
|
US |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Middle East Pharmaceutical Industries Company SJSC's stock price target?
Not Available
Middle East Pharmaceutical Industries Company SJSC does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Middle East Pharmaceutical Industries Company SJSC?
Projected CAGR
14%
14%
Over the last 4 years, the compound annual growth rate for Revenue has been 13%. The projected CAGR for the next 2 years is 14%.
What is the Gross Profit forecast for Middle East Pharmaceutical Industries Company SJSC?
Projected CAGR
17%
17%
Over the last 4 years, the compound annual growth rate for Gross Profit has been 13%. The projected CAGR for the next -1 years is 17%.
What is the Operating Income forecast for Middle East Pharmaceutical Industries Company SJSC?
Projected CAGR
15%
15%
Over the last 4 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 2 years is 15%.
What is the Pre-Tax Income forecast for Middle East Pharmaceutical Industries Company SJSC?
Projected CAGR
9%
9%
Over the last 4 years, the compound annual growth rate for Pre-Tax Income has been 10%. The projected CAGR for the next -1 years is 9%.
What is the Net Income forecast for Middle East Pharmaceutical Industries Company SJSC?
Projected CAGR
12%
12%
Over the last 4 years, the compound annual growth rate for Net Income has been 10%. The projected CAGR for the next -1 years is 12%.